Identification and Validation of Prognosis-Related Necroptosis Genes for Prognostic Prediction in Hepatocellular Carcinoma

Figure 4

Validation of the LASSO risk model based on the GSE14520 test cohort. (a) Distribution according to the risk scores. (b) Low-risk patients have favorable overall survival. (c) The prognosis of low-risk patients is better than that of high-risk patients, indicating that the risk model has a certain predictive value. (d) Two groups of HCC patients can be better distinguished according to PCA and t-SNE analysis.

(a)

(b)

(c)

(d)